메뉴 건너뛰기




Volumn 2016, Issue , 2016, Pages

Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CHEMOTHERAPY; CLINICAL TRIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PREVENTION; RADIATION; TUMOR ESCAPE; CENTRAL NERVOUS SYSTEM NEOPLASMS; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; GAMMA RADIATION; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOTHERAPY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; RADIATION RESPONSE; SIGNAL TRANSDUCTION; THERAPEUTIC USE;

EID: 84955581202     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/4683607     Document Type: Review
Times cited : (43)

References (177)
  • 1
    • 84862903106 scopus 로고    scopus 로고
    • Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
    • J. R. Brahmer, S. S. Tykodi, L. Q. M. Chow et al., "Safety and activity of anti-PD-L1 antibody in patients with advanced cancer, "The New England Journal of Medicine, vol. 366, no. 26, pp. 2455-2465, 2012.
    • (2012) The New England Journal of Medicine , vol.366 , Issue.26 , pp. 2455-2465
    • Brahmer, J.R.1    Tykodi, S.S.2    Chow, L.Q.M.3
  • 2
    • 84932628341 scopus 로고    scopus 로고
    • PD-1 blockade in tumors with mismatch-repair deficiency
    • D. T. Le, J. N. Uram, H. Wang et al., "PD-1 blockade in tumors with mismatch-repair deficiency, " The New England Journal of Medicine, vol. 372, no. 26, pp. 2509-2520, 2015.
    • (2015) The New England Journal of Medicine , vol.372 , Issue.26 , pp. 2509-2520
    • Le, D.T.1    Uram, J.N.2    Wang, H.3
  • 3
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • F. S. Hodi, S. J. ODay, D. F. McDermott et al., "Improved survival with ipilimumab in patients with metastatic melanoma, " The New England Journal of Medicine, vol. 363, no. 8, pp. 711-723, 2010.
    • (2011) The New England Journal of Medicine , vol.363 , Issue.8 , pp. 711-723
    • Hodi, F.S.1    ODay, S.J.2    McDermott, D.F.3
  • 5
    • 84877581852 scopus 로고    scopus 로고
    • Anti-PD-1 blockade and stereotactic radiation produce long-Term survival in mice with intracranial gliomas
    • J. Zeng, A. P. See, J. Phallen et al., "Anti-PD-1 blockade and stereotactic radiation produce long-Term survival in mice with intracranial gliomas, " International Journal of Radiation Oncology Biology Physics, vol. 86, no. 2, pp. 343-349, 2013.
    • (2013) International Journal of Radiation Oncology Biology Physics , vol.86 , Issue.2 , pp. 343-349
    • Zeng, J.1    See, A.P.2    Phallen, J.3
  • 6
    • 84899112560 scopus 로고    scopus 로고
    • Trial watch: Immunostimulatory monoclonal antibodies in cancer therapy
    • Article ID e27297
    • F. Aranda, E. Vacchelli, A. Eggermont et al., "Trial watch: immunostimulatory monoclonal antibodies in cancer therapy, " Oncoimmunology, vol. 3, no. 1, Article ID e27297, 2014.
    • (2014) Oncoimmunology , vol.3 , Issue.1
    • Aranda, F.1    Vacchelli, E.2    Eggermont, A.3
  • 7
    • 39149097490 scopus 로고    scopus 로고
    • Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study
    • A. B. Heimberger, W. Sun, S. F. Hussain et al., "Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: case study, " Neuro-Oncology, vol. 10, no. 1, pp. 98-103, 2008.
    • (2008) Neuro-Oncology , vol.10 , Issue.1 , pp. 98-103
    • Heimberger, A.B.1    Sun, W.2    Hussain, S.F.3
  • 8
    • 33748481603 scopus 로고    scopus 로고
    • An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme
    • A. El Andaloussi and M. S. Lesniak, "An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme, " Neuro-Oncology, vol. 8, no. 3, pp. 234-243, 2006.
    • (2006) Neuro-Oncology , vol.8 , Issue.3 , pp. 234-243
    • El Andaloussi, A.1    Lesniak, M.S.2
  • 9
    • 34247502076 scopus 로고    scopus 로고
    • Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
    • P. E. Fecci, H. Ochiai, D. A. Mitchell et al., "Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function, " Clinical Cancer Research, vol. 13, no. 7, pp. 2158-2167, 2007.
    • (2007) Clinical Cancer Research , vol.13 , Issue.7 , pp. 2158-2167
    • Fecci, P.E.1    Ochiai, H.2    Mitchell, D.A.3
  • 10
    • 61349100687 scopus 로고    scopus 로고
    • Myeloid-derived suppressor cells as regulators of the immune system
    • D. I. Gabrilovich and S. Nagaraj, "Myeloid-derived suppressor cells as regulators of the immune system, " Nature Reviews Immunology, vol. 9, no. 3, pp. 162-174, 2009.
    • (2009) Nature Reviews Immunology , vol.9 , Issue.3 , pp. 162-174
    • Gabrilovich, D.I.1    Nagaraj, S.2
  • 11
    • 84871336215 scopus 로고    scopus 로고
    • The role of STAT3 activation in modulating the immune microenvironment of GBM
    • A. P. See, J. E. Han, J. Phallen et al., "The role of STAT3 activation in modulating the immune microenvironment of GBM, " Journal of Neuro-Oncology, vol. 110, no. 3, pp. 359-368, 2012.
    • (2012) Journal of Neuro-Oncology , vol.110 , Issue.3 , pp. 359-368
    • See, A.P.1    Han, J.E.2    Phallen, J.3
  • 13
    • 34247552726 scopus 로고    scopus 로고
    • Stat3 as a potential target for cancer immunotherapy
    • M. Kortylewski and H. Yu, "Stat3 as a potential target for cancer immunotherapy, " Journal of Immunotherapy, vol. 30, no. 2, pp. 131-139, 2007.
    • (2007) Journal of Immunotherapy , vol.30 , Issue.2 , pp. 131-139
    • Kortylewski, M.1    Yu, H.2
  • 14
    • 84936871460 scopus 로고    scopus 로고
    • Structural and functional features of central nervous systemlymphatic vessels
    • A. Louveau, I. Smirnov, T. J. Keyes et al., "Structural and functional features of central nervous systemlymphatic vessels, " Nature, vol. 523, no. 7560, pp. 337-341, 2015.
    • (2015) Nature , vol.523 , Issue.7560 , pp. 337-341
    • Louveau, A.1    Smirnov, I.2    Keyes, T.J.3
  • 15
    • 0021206304 scopus 로고
    • Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies
    • R. I. von Hanwehr, F. M. Hofman, C. R. Taylor, and M. L. J. Apuzzo, "Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors. Characterization of cell subsets with monoclonal antibodies, " Journal of Neurosurgery, vol. 60, no. 6, pp. 1138-1147, 1984.
    • (1984) Journal of Neurosurgery , vol.60 , Issue.6 , pp. 1138-1147
    • Von Hanwehr, R.I.1    Hofman, F.M.2    Taylor, C.R.3    Apuzzo, M.L.J.4
  • 16
    • 0018068743 scopus 로고
    • Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases
    • L. Palma, N. Di Lorenzo, and B. Guidetti, "Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases, " Journal of Neurosurgery, vol. 49, no. 6, pp. 854-861, 1978.
    • (1978) Journal of Neurosurgery , vol.49 , Issue.6 , pp. 854-861
    • Palma, L.1    Di Lorenzo, N.2    Guidetti, B.3
  • 17
    • 0017864016 scopus 로고
    • Relationship of lymphocyte invasion and survival of brain tumor patients
    • W. H. Brooks, W. R. Markesbery, G. D. Gupta, and T. L. Roszman, "Relationship of lymphocyte invasion and survival of brain tumor patients, " Annals of Neurology, vol. 4, no. 3, pp. 219-224, 1978.
    • (1978) Annals of Neurology , vol.4 , Issue.3 , pp. 219-224
    • Brooks, W.H.1    Markesbery, W.R.2    Gupta, G.D.3    Roszman, T.L.4
  • 18
    • 0021151540 scopus 로고
    • Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma
    • D. K. Boker, R. Kalff, F. Gullotta, S. Weekes-Seifert, and U. Mhrer, "Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma, " Clinical Neuropathology, vol. 3, no. 4, pp. 143-147, 1984.
    • (1984) Clinical Neuropathology , vol.3 , Issue.4 , pp. 143-147
    • Boker, D.K.1    Kalff, R.2    Gullotta, F.3    Weekes-Seifert, S.4    Mhrer, U.5
  • 19
    • 0018394501 scopus 로고
    • Analysis of some factors effecting survival in malignant gliomas
    • D. Schiffer, D. Cavicchioli, M. T. Giordana, L. Palmucci, and A. Piazza, "Analysis of some factors effecting survival in malignant gliomas, " Tumori, vol. 65, no. 1, pp. 119-125, 1979.
    • (1979) Tumori , vol.65 , Issue.1 , pp. 119-125
    • Schiffer, D.1    Cavicchioli, D.2    Giordana, M.T.3    Palmucci, L.4    Piazza, A.5
  • 20
    • 0030853610 scopus 로고    scopus 로고
    • Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-Associated molecule-4 blockade: The effect is manifested only at the restricted tumor-bearing stages
    • Y.-F. Yang, J.-P. Zou, J. Mu et al., "Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-Associated molecule-4 blockade: The effect is manifested only at the restricted tumor-bearing stages, " Cancer Research, vol. 57, no. 18, pp. 4036-4041, 1997.
    • (1997) Cancer Research , vol.57 , Issue.18 , pp. 4036-4041
    • Yang, Y.-F.1    Zou, J.-P.2    Mu, J.3
  • 21
    • 0031881906 scopus 로고    scopus 로고
    • Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses
    • Y.-J. Kim, S. H. Kim, P. Mantel, and B. S. Kwon, "Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses, " European Journal of Immunology, vol. 28, no. 3, pp. 881-890, 1998.
    • (1998) European Journal of Immunology , vol.28 , Issue.3 , pp. 881-890
    • Kim, Y.-J.1    Kim, S.H.2    Mantel, P.3    Kwon, B.S.4
  • 22
    • 0036852241 scopus 로고    scopus 로고
    • Cancer immunoediting: From immunosurveillance to tumor escape
    • G. P. Dunn, A. T. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber, "Cancer immunoediting: from immunosurveillance to tumor escape, " Nature Immunology, vol. 3, no. 11, pp. 991-998, 2002.
    • (2002) Nature Immunology , vol.3 , Issue.11 , pp. 991-998
    • Dunn, G.P.1    Bruce, A.T.2    Ikeda, H.3    Old, L.J.4    Schreiber, R.D.5
  • 23
    • 79953151458 scopus 로고    scopus 로고
    • Cancer immunoediting: Integrating immunitys roles in cancer suppression and promotion
    • R. D. Schreiber, L. J. Old, and M. J. Smyth, "Cancer immunoediting: integrating immunitys roles in cancer suppression and promotion, " Science, vol. 331, no. 6024, pp. 1565-1570, 2011.
    • (2011) Science , vol.331 , Issue.6024 , pp. 1565-1570
    • Schreiber, R.D.1    Old, L.J.2    Smyth, M.J.3
  • 24
    • 84859158384 scopus 로고    scopus 로고
    • Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-Tumor immunity
    • S. L. Topalian, C. G. Drake, and D. M. Pardoll, "Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-Tumor immunity, " Current Opinion in Immunology, vol. 245, no. 2, pp. 207-212, 2012.
    • (2012) Current Opinion in Immunology , vol.245 , Issue.2 , pp. 207-212
    • Topalian, S.L.1    Drake, C.G.2    Pardoll, D.M.3
  • 27
    • 0036669785 scopus 로고    scopus 로고
    • The interaction properties of costimulatorymolecules revisited
    • A.V. Collins, D.W. Brodie, R. J. C. Gilbert et al., "The interaction properties of costimulatorymolecules revisited, " Immunity, vol. 17, no. 2, pp. 201-210, 2002.
    • (2002) Immunity , vol.17 , Issue.2 , pp. 201-210
    • Collins, A.V.1    Brodie, D.W.2    Gilbert, R.J.C.3
  • 28
    • 0028675006 scopus 로고
    • Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
    • P. S. Linsley, J. L. Greene, W. Brady, J. Bajorath, J. A. Ledbetter, and R. Peach, "Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors, " Immunity, vol. 1, no. 9, pp. 793-801, 1994.
    • (1994) Immunity , vol.1 , Issue.9 , pp. 793-801
    • Linsley, P.S.1    Greene, J.L.2    Brady, W.3    Bajorath, J.4    Ledbetter, J.A.5    Peach, R.6
  • 29
    • 0027937702 scopus 로고
    • Complementarity determining region 1 (CDR1)-And CDR3-Analogous regions in CTLA-4 and CD28 determine the binding to B7-1
    • R. J. Peach, J. Bajorath, W. Brady et al., "Complementarity determining region 1 (CDR1)-And CDR3-Analogous regions in CTLA-4 and CD28 determine the binding to B7-1, " The Journal of Experimental Medicine, vol. 180, no. 6, pp. 2049-2058, 1994.
    • (1994) The Journal of Experimental Medicine , vol.180 , Issue.6 , pp. 2049-2058
    • Peach, R.J.1    Bajorath, J.2    Brady, W.3
  • 30
    • 0027282960 scopus 로고
    • Characterization of CTLA-4 structure and expression on human T cells
    • T. Lindsten, K. P. Lee, E. S. Harris et al., "Characterization of CTLA-4 structure and expression on human T cells, " The Journal of Immunology, vol. 151, no. 7, pp. 3489-3499, 1993.
    • (1993) The Journal of Immunology , vol.151 , Issue.7 , pp. 3489-3499
    • Lindsten, T.1    Lee, K.P.2    Harris, E.S.3
  • 31
    • 65349119978 scopus 로고    scopus 로고
    • CD28 and CTLA-4 coreceptor expression and signal transduction
    • C. E. Rudd, A. Taylor, and H. Schneider, "CD28 and CTLA-4 coreceptor expression and signal transduction, " Immunological Reviews, vol. 229, no. 1, pp. 12-26, 2009.
    • (2009) Immunological Reviews , vol.229 , Issue.1 , pp. 12-26
    • Rudd, C.E.1    Taylor, A.2    Schneider, H.3
  • 32
    • 0033662376 scopus 로고    scopus 로고
    • The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A
    • E. Chuang, T. S. Fisher, R. W. Morgan et al., "The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A, " Immunity, vol. 13, no. 3, pp. 313-322, 2000.
    • (2000) Immunity , vol.13 , Issue.3 , pp. 313-322
    • Chuang, E.1    Fisher, T.S.2    Morgan, R.W.3
  • 33
    • 0033048961 scopus 로고    scopus 로고
    • CTLA4 ligation attenuates AP-1, NFAT and NF-B activity in activated T cells
    • J.H. Fraser, M. Rincn, K. D. McCoy, and G. L. Gros, "CTLA4 ligation attenuates AP-1, NFAT and NF-B activity in activated T cells, " European Journal of Immunology, vol. 29, no. 3, pp. 838-844, 1999.
    • (1999) European Journal of Immunology , vol.29 , Issue.3 , pp. 838-844
    • Fraser, J.H.1    Rincn, M.2    McCoy, K.D.3    Gros, G.L.4
  • 34
    • 79954459308 scopus 로고    scopus 로고
    • Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family
    • H. Bour-Jordan, J. H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J. A. Bluestone, "Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family, " Immunological Reviews, vol. 241, no. 1, pp. 180-205, 2011.
    • (2011) Immunological Reviews , vol.241 , Issue.1 , pp. 180-205
    • Bour-Jordan, H.1    Esensten, J.H.2    Martinez-Llordella, M.3    Penaranda, C.4    Stumpf, M.5    Bluestone, J.A.6
  • 35
    • 0037244012 scopus 로고    scopus 로고
    • Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-Associated antigen 4
    • S. Chikuma, J. B. Imboden, and J. A. Bluestone, "Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-Associated antigen 4, " The Journal of Experimental Medicine, vol. 197, no. 1, pp. 129-135, 2003.
    • (2003) The Journal of Experimental Medicine , vol.197 , Issue.1 , pp. 129-135
    • Chikuma, S.1    Imboden, J.B.2    Bluestone, J.A.3
  • 36
    • 0035803552 scopus 로고    scopus 로고
    • Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function
    • M. Martin, H. Schneider, A. Azouz, and C. E. Rudd, "Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell function, " Journal of Experimental Medicine, vol. 194, no. 11, pp. 1675-1681, 2001.
    • (2001) Journal of Experimental Medicine , vol.194 , Issue.11 , pp. 1675-1681
    • Martin, M.1    Schneider, H.2    Azouz, A.3    Rudd, C.E.4
  • 37
    • 38349074305 scopus 로고    scopus 로고
    • CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization
    • H. Schneider, X. Smith, H. Liu, G. Bismuth, and C. E. Rudd, "CTLA-4 disrupts ZAP70 microcluster formation with reduced T cell/APC dwell times and calcium mobilization, " European Journal of Immunology, vol. 38, no. 1, pp. 40-47, 2008.
    • (2008) European Journal of Immunology , vol.38 , Issue.1 , pp. 40-47
    • Schneider, H.1    Smith, X.2    Liu, H.3    Bismuth, G.4    Rudd, C.E.5
  • 38
    • 0035869583 scopus 로고    scopus 로고
    • Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-Transgenic T cells: Lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase
    • T. F. Gajewski, F. Fallarino, P. E. Fields, F. Rivas, and M.-L. Alegre, "Absence of CTLA-4 lowers the activation threshold of primed CD8+ TCR-Transgenic T cells: lack of correlation with Src homology domain 2-containing protein tyrosine phosphatase, " The Journal of Immunology, vol. 166, no. 6, pp. 3900-3907, 2001.
    • (2001) The Journal of Immunology , vol.166 , Issue.6 , pp. 3900-3907
    • Gajewski, T.F.1    Fallarino, F.2    Fields, P.E.3    Rivas, F.4    Alegre, M.-L.5
  • 39
    • 0030443168 scopus 로고    scopus 로고
    • Regulation of surface and intracellular expression of CTLA4 on mouse T cells
    • M.-L. Alegre, P. J. Noel, B. J. Eisfelder et al., "Regulation of surface and intracellular expression of CTLA4 on mouse T cells, " Journal of Immunology, vol. 157, no. 11, pp. 4762-4770, 1996.
    • (1996) Journal of Immunology , vol.157 , Issue.11 , pp. 4762-4770
    • Alegre, M.-L.1    Noel, P.J.2    Eisfelder, B.J.3
  • 40
    • 79955529454 scopus 로고    scopus 로고
    • Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4
    • O. S. Qureshi, Y. Zheng, K. Nakamura et al., "Trans-endocytosis of CD80 and CD86: A molecular basis for the cell-extrinsic function of CTLA-4, " Science, vol. 332, no. 6029, pp. 600-603, 2011.
    • (2011) Science , vol.332 , Issue.6029 , pp. 600-603
    • Qureshi, O.S.1    Zheng, Y.2    Nakamura, K.3
  • 41
    • 84858766182 scopus 로고    scopus 로고
    • The blockade of immune checkpoints in cancer immunotherapy
    • D. M. Pardoll, "The blockade of immune checkpoints in cancer immunotherapy, " Nature Reviews Cancer, vol. 12, no. 4, pp. 252-264, 2012.
    • (2012) Nature Reviews Cancer , vol.12 , Issue.4 , pp. 252-264
    • Pardoll, D.M.1
  • 42
    • 0028791059 scopus 로고
    • Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
    • P. Waterhouse, J.M. Penninger, E. Timms et al., "Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4, " Science, vol. 270, no. 5238, pp. 985-988, 1995.
    • (1995) Science , vol.270 , Issue.5238 , pp. 985-988
    • Waterhouse, P.1    Penninger, J.M.2    Timms, E.3
  • 43
    • 0031405867 scopus 로고    scopus 로고
    • Lymphoproliferation inCTLA-4-deficient mice ismediated by costimulationdependent activation of CD4+ T cells
    • C.A. Chambers, T. J. Sullivan, and J. P. Allison, "Lymphoproliferation inCTLA-4-deficient mice ismediated by costimulationdependent activation of CD4+ T cells, " Immunity, vol. 7, no. 6, pp. 885-895, 1997.
    • (1997) Immunity , vol.7 , Issue.6 , pp. 885-895
    • Chambers, C.A.1    Sullivan, T.J.2    Allison, J.P.3
  • 44
    • 0035059417 scopus 로고    scopus 로고
    • Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation
    • B. Salomon and J. A. Bluestone, "Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation, " Annual Review of Immunology, vol. 19, pp. 225-252, 2001.
    • (2001) Annual Review of Immunology , vol.19 , pp. 225-252
    • Salomon, B.1    Bluestone, J.A.2
  • 45
    • 0031278368 scopus 로고    scopus 로고
    • T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors
    • L. A. Morford, L. H. Elliott, S. L. Carlson, W. H. Brooks, and T. L. Roszman, "T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors, " Journal of Immunology, vol. 159, no. 9, pp. 4415-4425, 1997.
    • (1997) Journal of Immunology , vol.159 , Issue.9 , pp. 4415-4425
    • Morford, L.A.1    Elliott, L.H.2    Carlson, S.L.3    Brooks, W.H.4    Roszman, T.L.5
  • 46
    • 0018832524 scopus 로고
    • Immunobiology of primary intracranial tumours. III. Demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours
    • T. L. Roszman and W. H. Brooks, "Immunobiology of primary intracranial tumours. III. demonstration of a qualitative lymphocyte abnormality in patients with primary brain tumours, " Clinical&Experimental Immunology, vol. 39, no. 2, pp. 395-402, 1980.
    • (1980) Clinical&Experimental Immunology , vol.39 , Issue.2 , pp. 395-402
    • Roszman, T.L.1    Brooks, W.H.2
  • 48
    • 0141891466 scopus 로고    scopus 로고
    • Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers
    • F. Ichihara, K. Kono, A. Takahashi, H. Kawaida, H. Sugai, and H. Fujii, "Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers, " Clinical Cancer Research, vol. 9, no. 12, pp. 4404-4408, 2003.
    • (2003) Clinical Cancer Research , vol.9 , Issue.12 , pp. 4404-4408
    • Ichihara, F.1    Kono, K.2    Takahashi, A.3    Kawaida, H.4    Sugai, H.5    Fujii, H.6
  • 49
    • 27644593923 scopus 로고    scopus 로고
    • Human CTLA4 knockin mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies
    • K. D. Lute, K. F. May Jr., P. Lu et al., "Human CTLA4 knockin mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies, " Blood, vol. 106, no. 9, pp. 3127-3133, 2005.
    • (2005) Blood , vol.106 , Issue.9 , pp. 3127-3133
    • Lute, K.D.1    May, K.F.2    Lu, P.3
  • 50
    • 0036721629 scopus 로고    scopus 로고
    • Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
    • U. K. Liyanage, T. T. Moore, H.-G. Joo et al., "Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, "TheJournal of Immunology, vol. 169, no. 5, pp. 2756-2761, 2002.
    • (2002) The Journal of Immunology , vol.169 , Issue.5 , pp. 2756-2761
    • Liyanage, U.K.1    Moore, T.T.2    Joo, H.-G.3
  • 51
    • 0041386189 scopus 로고    scopus 로고
    • CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: Possible involvement of regulatory T cells in disease progression
    • T. Sasada, M. Kimura, Y. Yoshida, M. Kanai, and A. Takabayashi, "CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression, " Cancer, vol. 98, no. 5, pp. 1089-1099, 2003.
    • (2003) Cancer , vol.98 , Issue.5 , pp. 1089-1099
    • Sasada, T.1    Kimura, M.2    Yoshida, Y.3    Kanai, M.4    Takabayashi, A.5
  • 52
    • 0035874949 scopus 로고    scopus 로고
    • Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
    • E. Y. Woo, C. S. Chu, T. J. Goletz et al., "Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer, " Cancer Research, vol. 61, no. 12, pp. 4766-4772, 2001.
    • (2001) Cancer Research , vol.61 , Issue.12 , pp. 4766-4772
    • Woo, E.Y.1    Chu, C.S.2    Goletz, T.J.3
  • 53
    • 33645502885 scopus 로고    scopus 로고
    • Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
    • P. E. Fecci, D. A. Mitchell, J. F. Whitesides et al., "Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma, " Cancer Research, vol. 66, no. 6, pp. 3294-3302, 2006.
    • (2006) Cancer Research , vol.66 , Issue.6 , pp. 3294-3302
    • Fecci, P.E.1    Mitchell, D.A.2    Whitesides, J.F.3
  • 54
    • 34248172651 scopus 로고    scopus 로고
    • CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo
    • O. M. Grauer, S. Nierkens, E. Bennink et al., "CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo, " International Journal of Cancer, vol. 121, no. 1, pp. 95-105, 2007.
    • (2007) International Journal of Cancer , vol.121 , Issue.1 , pp. 95-105
    • Grauer, O.M.1    Nierkens, S.2    Bennink, E.3
  • 55
    • 84861233216 scopus 로고    scopus 로고
    • Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors
    • P. Agarwalla, Z. Barnard, P. Fecci, G. Dranoff, and W. T. Curry Jr., "Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors, " Journal of Immunotherapy, vol. 35, no. 5, pp. 385-389, 2012.
    • (2012) Journal of Immunotherapy , vol.35 , Issue.5 , pp. 385-389
    • Agarwalla, P.1    Barnard, Z.2    Fecci, P.3    Dranoff, G.4    Curry, W.T.5
  • 56
    • 84876678621 scopus 로고    scopus 로고
    • Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma
    • J. S. Weber, R. Dummer, V. de Pril, C. Lebb, and F. S. Hodi, "Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma, " Cancer, vol. 119, no. 9, pp. 1675-1682, 2013.
    • (2013) Cancer , vol.119 , Issue.9 , pp. 1675-1682
    • Weber, J.S.1    Dummer, R.2    De Pril, V.3    Lebb, C.4    Hodi, F.S.5
  • 58
    • 0032736029 scopus 로고    scopus 로고
    • B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
    • H. Dong, G. Zhu, K. Tamada, and L. Chen, "B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion, " Nature Medicine, vol. 5, no. 12, pp. 1365-1369, 1999.
    • (1999) Nature Medicine , vol.5 , Issue.12 , pp. 1365-1369
    • Dong, H.1    Zhu, G.2    Tamada, K.3    Chen, L.4
  • 59
    • 5844264920 scopus 로고    scopus 로고
    • PD-L2 is a second ligand for PD-1 and inhibits T cell activation
    • Y. Latchman, C. R. Wood, T. Chernova et al., "PD-L2 is a second ligand for PD-1 and inhibits T cell activation, " Nature Immunology, vol. 2, no. 3, pp. 261-268, 2001.
    • (2001) Nature Immunology , vol.2 , Issue.3 , pp. 261-268
    • Latchman, Y.1    Wood, C.R.2    Chernova, T.3
  • 62
    • 84863089861 scopus 로고    scopus 로고
    • Selective effects of PD-1 on Akt and ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation
    • article ra46
    • N. Patsoukis, J. Brown, V. Petkova, F. Liu, L. Li, and V. A. Boussiotis, "Selective effects of PD-1 on Akt and ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation, " Science Signaling, vol. 5, no. 230, article ra46, 2012.
    • (2012) Science Signaling , vol.5 , Issue.230
    • Patsoukis, N.1    Brown, J.2    Petkova, V.3    Liu, F.4    Li, L.5    Boussiotis, V.A.6
  • 63
    • 33645846313 scopus 로고    scopus 로고
    • Tissue expressionof PDL1 mediates peripheral T cell tolerance
    • M.E. Keir, S. C. Liang, I. Guleria et al., "Tissue expressionof PDL1 mediates peripheral T cell tolerance, " Journal of Experimental Medicine, vol. 203, no. 4, pp. 883-895, 2006.
    • (2006) Journal of Experimental Medicine , vol.203 , Issue.4 , pp. 883-895
    • Keir, M.E.1    Liang, S.C.2    Guleria, I.3
  • 64
    • 27144496045 scopus 로고    scopus 로고
    • CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
    • R. V. Parry, J. M. Chemnitz, K. A. Frauwirth et al., "CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms, "Molecular and Cellular Biology, vol. 25, no. 21, pp. 9543-9553, 2005.
    • (2005) Molecular and Cellular Biology , vol.25 , Issue.21 , pp. 9543-9553
    • Parry, R.V.1    Chemnitz, J.M.2    Frauwirth, K.A.3
  • 65
    • 0034596948 scopus 로고    scopus 로고
    • Engagement of the PD-1 immunoinhibitory receptor by a novel B7 familymember leads to negative regulation of lymphocyte activation
    • G. J. Freeman, A. J. Long, Y. Iwai et al., "Engagement of the PD-1 immunoinhibitory receptor by a novel B7 familymember leads to negative regulation of lymphocyte activation, " The Journal of Experimental Medicine, vol. 192, no. 7, pp. 1027-1034, 2000.
    • (2000) The Journal of Experimental Medicine , vol.192 , Issue.7 , pp. 1027-1034
    • Freeman, G.J.1    Long, A.J.2    Iwai, Y.3
  • 66
    • 0036207926 scopus 로고    scopus 로고
    • PD-1:PD-L inhibitory pathway affects bothCD4+ andCD8+ Tcells and is overcome by IL-2
    • L. Carter, L. A. Fouser, J. Jussif et al., "PD-1:PD-L inhibitory pathway affects bothCD4+ andCD8+ Tcells and is overcome by IL-2, " European Journal of Immunology, vol. 32, no. 3, pp. 634-643, 2002.
    • (2002) European Journal of Immunology , vol.32 , Issue.3 , pp. 634-643
    • Carter, L.1    Fouser, L.A.2    Jussif, J.3
  • 67
    • 0242442492 scopus 로고    scopus 로고
    • Expression of the B7-related molecule B7-H1 by glioma cells: A potential mechanism of immune paralysis
    • S. Wintterle, B. Schreiner, M. Mitsdoerffer et al., "Expression of the B7-related molecule B7-H1 by glioma cells: A potential mechanism of immune paralysis, " Cancer Research, vol. 63, no. 21, pp. 7462-7467, 2003.
    • (2003) Cancer Research , vol.63 , Issue.21 , pp. 7462-7467
    • Wintterle, S.1    Schreiner, B.2    Mitsdoerffer, M.3
  • 68
    • 33846118474 scopus 로고    scopus 로고
    • Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
    • A. T. Parsa, J. S. Waldron, A. Panner et al., "Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma, " Nature Medicine, vol. 13, no. 1, pp. 84-88, 2007.
    • (2007) Nature Medicine , vol.13 , Issue.1 , pp. 84-88
    • Parsa, A.T.1    Waldron, J.S.2    Panner, A.3
  • 69
    • 77955665451 scopus 로고    scopus 로고
    • Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2, 3-dioxygenase (IDO) on tumour-specific T cell functions
    • T. Avril, S. Saikali, E. Vauleon et al., "Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2, 3-dioxygenase (IDO) on tumour-specific T cell functions, " Journal of Neuroimmunology, vol. 225, no. 1-2, pp. 22-33, 2010.
    • (2011) Journal of Neuroimmunology , vol.225 , Issue.1-2 , pp. 22-33
    • Avril, T.1    Saikali, S.2    Vauleon, E.3
  • 70
    • 68949085209 scopus 로고    scopus 로고
    • Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
    • J. F.M. Jacobs, A. J. Idema, K. F. Bol et al., "Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors, " Neuro-Oncology, vol. 11, no. 4, pp. 394-402, 2009.
    • (2009) Neuro-Oncology , vol.11 , Issue.4 , pp. 394-402
    • Jacobs, J.F.M.1    Idema, A.J.2    Bol, K.F.3
  • 71
    • 22544486023 scopus 로고    scopus 로고
    • B7-homolog 1 expression by human glioma: A new mechanism of immune evasion
    • R. Wilmotte, K. Burkhardt, V. Kindler et al., "B7-homolog 1 expression by human glioma: A new mechanism of immune evasion, " Neuroreport, vol. 16, no. 10, pp. 1081-1085, 2005.
    • (2005) Neuroreport , vol.16 , Issue.10 , pp. 1081-1085
    • Wilmotte, R.1    Burkhardt, K.2    Kindler, V.3
  • 72
    • 9144255487 scopus 로고    scopus 로고
    • Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)
    • N. Li, C. J. Workman, S. M. Martin, and D. A. A. Vignali, "Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223), "The Journal of Immunology, vol. 173, no. 11, pp. 6806-6812, 2004.
    • (2004) The Journal of Immunology , vol.173 , Issue.11 , pp. 6806-6812
    • Li, N.1    Workman, C.J.2    Martin, S.M.3    Vignali, D.A.A.4
  • 73
    • 0038068048 scopus 로고    scopus 로고
    • The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated Tcells
    • C. J. Workman and D. A. A. Vignali, "The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated Tcells, " European Journal of Immunology, vol. 33, no. 4, pp. 970-979, 2003.
    • (2003) European Journal of Immunology , vol.33 , Issue.4 , pp. 970-979
    • Workman, C.J.1    Vignali, D.A.A.2
  • 74
    • 0032532284 scopus 로고    scopus 로고
    • CD3/TCR complex-Associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling
    • S. Hannier, M. Tournier, G. Bismuth, and F. Triebel, "CD3/TCR complex-Associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling, " The Journal of Immunology, vol. 161, no. 8, pp. 4058-4065, 1998.
    • (1998) The Journal of Immunology , vol.161 , Issue.8 , pp. 4058-4065
    • Hannier, S.1    Tournier, M.2    Bismuth, G.3    Triebel, F.4
  • 75
    • 0344440962 scopus 로고    scopus 로고
    • LAG-3: A regulator of T-cell and DC responses and its use in therapeutic vaccination
    • F. Triebel, "LAG-3: A regulator of T-cell and DC responses and its use in therapeutic vaccination, " Trends in Immunology, vol. 24, no. 12, pp. 619-622, 2003.
    • (2003) Trends in Immunology , vol.24 , Issue.12 , pp. 619-622
    • Triebel, F.1
  • 76
    • 0037090060 scopus 로고    scopus 로고
    • Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223)
    • S. Andreae, F. Piras, N. Burdin, and F. Triebel, "Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223), " The Journal of Immunology, vol. 168, no. 8, pp. 3874-3880, 2002.
    • (2002) The Journal of Immunology , vol.168 , Issue.8 , pp. 3874-3880
    • Andreae, S.1    Piras, F.2    Burdin, N.3    Triebel, F.4
  • 77
    • 9344236517 scopus 로고    scopus 로고
    • Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-production
    • F. Annunziato, R. Manetti, L. Tomasvic et al., "Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-production, " The FASEB Journal, vol. 10, no. 7, pp. 769-776, 1996.
    • (1996) The FASEB Journal , vol.10 , Issue.7 , pp. 769-776
    • Annunziato, F.1    Manetti, R.2    Tomasvic, L.3
  • 78
    • 5644263642 scopus 로고    scopus 로고
    • Role of LAG-3 in regulatory T cells
    • C.-T. Huang, C. J. Workman, D. Flies et al., "Role of LAG-3 in regulatory T cells, " Immunity, vol. 21, no. 4, pp. 503-513, 2004.
    • (2004) Immunity , vol.21 , Issue.4 , pp. 503-513
    • Huang, C.-T.1    Workman, C.J.2    Flies, D.3
  • 80
    • 36048963838 scopus 로고    scopus 로고
    • LAG-3 regulates CD8+ T cell accumulation and effector function in murine self-And tumor-Tolerance systems
    • J. F. Grosso, C. C. Kelleher, T. J. Harris et al., "LAG-3 regulates CD8+ T cell accumulation and effector function in murine self-And tumor-Tolerance systems, " The Journal of Clinical Investigation, vol. 117, no. 11, pp. 3383-3392, 2007.
    • (2007) The Journal of Clinical Investigation , vol.117 , Issue.11 , pp. 3383-3392
    • Grosso, J.F.1    Kelleher, C.C.2    Harris, T.J.3
  • 81
    • 84863115998 scopus 로고    scopus 로고
    • Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape
    • S.-R. Woo, M. E. Turnis, M. V. Goldberg et al., "Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape, " Cancer Research, vol. 72, no. 4, pp. 917-927, 2012.
    • (2012) Cancer Research , vol.72 , Issue.4 , pp. 917-927
    • Woo, S.-R.1    Turnis, M.E.2    Goldberg, M.V.3
  • 84
    • 0031048272 scopus 로고    scopus 로고
    • Identification and characterization of galectin-9, a novel-galactoside-bindingmammalian lectin
    • J. Wada and Y. S. Kanwar, "Identification and characterization of galectin-9, a novel-galactoside-bindingmammalian lectin, " The Journal of Biological Chemistry, vol. 272, no. 9, pp. 6078-6086, 1997.
    • (1997) The Journal of Biological Chemistry , vol.272 , Issue.9 , pp. 6078-6086
    • Wada, J.1    Kanwar, Y.S.2
  • 85
    • 30044434075 scopus 로고    scopus 로고
    • The tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
    • C. Zhu, A. C. Anderson, A. Schubart et al., "The tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity, " Nature Immunology, vol. 6, no. 12, pp. 1245-1252, 2005.
    • (2005) Nature Immunology , vol.6 , Issue.12 , pp. 1245-1252
    • Zhu, C.1    Anderson, A.C.2    Schubart, A.3
  • 86
    • 79955977180 scopus 로고    scopus 로고
    • Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acutemyelogenous leukemia
    • Q. Zhou, M. E. Munger, R. G. Veenstra et al., "Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acutemyelogenous leukemia, " Blood, vol. 117, no. 17, pp. 4501-4510, 2011.
    • (2011) Blood , vol.117 , Issue.17 , pp. 4501-4510
    • Zhou, Q.1    Munger, M.E.2    Veenstra, R.G.3
  • 87
    • 69449091993 scopus 로고    scopus 로고
    • Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells
    • L. Golden-Mason, B. E. Palmer, N. Kassam et al., "Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells, " Journal of Virology, vol. 83, no. 18, pp. 9122-9130, 2009.
    • (2009) Journal of Virology , vol.83 , Issue.18 , pp. 9122-9130
    • Golden-Mason, L.1    Palmer, B.E.2    Kassam, N.3
  • 88
    • 78649903057 scopus 로고    scopus 로고
    • Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity
    • R. H. McMahan, L. Golden-Mason, M. I. Nishimura et al., "Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity, "The Journal of Clinical Investigation, vol. 120, no. 12, pp. 4546-4557, 2010.
    • (2011) The Journal of Clinical Investigation , vol.120 , Issue.12 , pp. 4546-4557
    • McMahan, R.H.1    Golden-Mason, L.2    Nishimura, M.I.3
  • 90
    • 77957723967 scopus 로고    scopus 로고
    • Upregulation of Tim-3 and PD-1 expression is associated with tumor antigenspecific CD8+ T cell dysfunction in melanoma patients
    • J. Fourcade, Z. Sun, M. Benallaoua et al., "Upregulation of Tim-3 and PD-1 expression is associated with tumor antigenspecific CD8+ T cell dysfunction in melanoma patients, " Journal of Experimental Medicine, vol. 207, no. 10, pp. 2175-2186, 2010.
    • (2011) Journal of Experimental Medicine , vol.207 , Issue.10 , pp. 2175-2186
    • Fourcade, J.1    Sun, Z.2    Benallaoua, M.3
  • 92
    • 77956409684 scopus 로고    scopus 로고
    • Tim-3/galectin-9 pathway: Regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells
    • V. Dardalhon, A. C. Anderson, J. Karman et al., "Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells, " The Journal of Immunology, vol. 185, no. 3, pp. 1383-1392, 2010.
    • (2011) The Journal of Immunology , vol.185 , Issue.3 , pp. 1383-1392
    • Dardalhon, V.1    Anderson, A.C.2    Karman, J.3
  • 93
    • 0033588952 scopus 로고    scopus 로고
    • In vivo expression of natural killer cell inhibitory receptors by human melanomaspecific cytolytic T lymphocytes
    • D. E. Speiser, M. J. Pittet, D. Valmori et al., "In vivo expression of natural killer cell inhibitory receptors by human melanomaspecific cytolytic T lymphocytes, " The Journal of Experimental Medicine, vol. 190, no. 6, pp. 775-782, 1999.
    • (1999) The Journal of Experimental Medicine , vol.190 , Issue.6 , pp. 775-782
    • Speiser, D.E.1    Pittet, M.J.2    Valmori, D.3
  • 94
    • 0031046201 scopus 로고    scopus 로고
    • Killer cell inhibitory receptors: Diversity, specificity, and function
    • E. O. Long, D. N. Burshtyn, W. P. Clark et al., "Killer cell inhibitory receptors: diversity, specificity, and function, " Immunological Reviews, vol. 155, pp. 135-144, 1997.
    • (1997) Immunological Reviews , vol.155 , pp. 135-144
    • Long, E.O.1    Burshtyn, D.N.2    Clark, W.P.3
  • 95
    • 0030024788 scopus 로고    scopus 로고
    • Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor
    • D. N. Burshtyn, A. M. Scharenberg, N. Wagtmann et al., "Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor, " Immunity, vol. 4, no. 1, pp. 77-85, 1996.
    • (1996) Immunity , vol.4 , Issue.1 , pp. 77-85
    • Burshtyn, D.N.1    Scharenberg, A.M.2    Wagtmann, N.3
  • 96
    • 0030470555 scopus 로고    scopus 로고
    • Human natural killer cell receptors involved in MHC class i recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits
    • S. Lazetic, C. Chang, J. P. Houchins, L. L. Lanier, and J. H. Phillips, "Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits, " Journal of Immunology, vol. 157, no. 11, pp. 4741-4745, 1996.
    • (1996) Journal of Immunology , vol.157 , Issue.11 , pp. 4741-4745
    • Lazetic, S.1    Chang, C.2    Houchins, J.P.3    Lanier, L.L.4    Phillips, J.H.5
  • 97
    • 0030039386 scopus 로고    scopus 로고
    • The human leukocyte antigen (HLA)-C-specific activatory or inhibitory natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
    • R. Biassoni, C. Cantoni, M. Falco et al., "The human leukocyte antigen (HLA)-C-specific activatory or inhibitory natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions, " Journal of Experimental Medicine, vol. 183, no. 2, pp. 645-650, 1996.
    • (1996) Journal of Experimental Medicine , vol.183 , Issue.2 , pp. 645-650
    • Biassoni, R.1    Cantoni, C.2    Falco, M.3
  • 98
    • 0029015726 scopus 로고
    • Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-And intracellular domains
    • N. Wagtmann, R. Biassoni, C. Cantoni et al., "Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-And intracellular domains, " Immunity, vol. 2, no. 5, pp. 439-449, 1995.
    • (1995) Immunity , vol.2 , Issue.5 , pp. 439-449
    • Wagtmann, N.1    Biassoni, R.2    Cantoni, C.3
  • 99
    • 0036945657 scopus 로고    scopus 로고
    • The killer cell immunoglobulin-like receptor (KIR) genomic region: Geneorder, haplotypes and allelic polymorphism
    • K. C. Hsu, S. Chida, D. E. Geraghty, and B. Dupont, "The killer cell immunoglobulin-like receptor (KIR) genomic region: geneorder, haplotypes and allelic polymorphism, " Immunological Reviews, vol. 190, pp. 40-52, 2002.
    • (2002) Immunological Reviews , vol.190 , pp. 40-52
    • Hsu, K.C.1    Chida, S.2    Geraghty, D.E.3    Dupont, B.4
  • 102
    • 65549133016 scopus 로고    scopus 로고
    • Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation
    • J. Yu, J. M. Venstrom, X.-R. Liu et al., "Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation, " Blood, vol. 113, no. 16, pp. 3875-3884, 2009.
    • (2009) Blood , vol.113 , Issue.16 , pp. 3875-3884
    • Yu, J.1    Venstrom, J.M.2    Liu, X.-R.3
  • 103
    • 34247595404 scopus 로고    scopus 로고
    • Prospects for the use of NK cells in immunotherapy of human cancer
    • H.-G. Ljunggren and K.-J. Malmberg, "Prospects for the use of NK cells in immunotherapy of human cancer, " Nature Reviews Immunology, vol. 7, no. 5, pp. 329-339, 2007.
    • (2007) Nature Reviews Immunology , vol.7 , Issue.5 , pp. 329-339
    • Ljunggren, H.-G.1    Malmberg, K.-J.2
  • 104
    • 1542380606 scopus 로고    scopus 로고
    • Unravelling natural killer cell function: Triggering and inhibitory human NK receptors
    • L. Moretta and A. Moretta, "Unravelling natural killer cell function: Triggering and inhibitory human NK receptors, " The EMBO Journal, vol. 23, no. 2, pp. 255-259, 2004.
    • (2004) The EMBO Journal , vol.23 , Issue.2 , pp. 255-259
    • Moretta, L.1    Moretta, A.2
  • 105
    • 36549023879 scopus 로고    scopus 로고
    • NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation
    • L. Ruggeri, A. Mancusi, E. Burchielli et al., "NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation, " Blood Cells, Molecules, and Diseases, vol. 40, no. 1, pp. 84-90, 2008.
    • (2008) Blood Cells, Molecules, and Diseases , vol.40 , Issue.1 , pp. 84-90
    • Ruggeri, L.1    Mancusi, A.2    Burchielli, E.3
  • 106
    • 20144388509 scopus 로고    scopus 로고
    • Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
    • J. S. Miller, Y. Soignier, A. Panoskaltsis-Mortari et al., "Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, " Blood, vol. 105, no. 8, pp. 3051-3057, 2005.
    • (2005) Blood , vol.105 , Issue.8 , pp. 3051-3057
    • Miller, J.S.1    Soignier, Y.2    Panoskaltsis-Mortari, A.3
  • 107
    • 0025300414 scopus 로고
    • In search of the missing self : MHC molecules and NK cell recognition
    • H.-G. Ljunggren and K. Krre, "In search of the missing self : MHC molecules and NK cell recognition, " Immunology Today, vol. 11, no. 7, pp. 237-244, 1990.
    • (1990) Immunology Today , vol.11 , Issue.7 , pp. 237-244
    • Ljunggren, H.-G.1    Krre, K.2
  • 108
    • 0022317963 scopus 로고
    • Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
    • H.-G. Ljunggren and K. Karre, "Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism, "The Journal of Experimental Medicine, vol. 162, no. 6, pp. 1745-1759, 1985.
    • (1985) The Journal of Experimental Medicine , vol.162 , Issue.6 , pp. 1745-1759
    • Ljunggren, H.-G.1    Karre, K.2
  • 109
    • 0022616253 scopus 로고
    • Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
    • K. Karre, H. G. Ljunggren, G. Piontek, and R. Kiessling, "Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy, " Nature, vol. 319, no. 6055, pp. 675-678, 1986.
    • (1986) Nature , vol.319 , Issue.6055 , pp. 675-678
    • Karre, K.1    Ljunggren, H.G.2    Piontek, G.3    Kiessling, R.4
  • 110
    • 10744230735 scopus 로고    scopus 로고
    • Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
    • S. Giebel, F. Locatelli, T. Lamparelli et al., "Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors, " Blood, vol. 102, no. 3, pp. 814-819, 2003.
    • (2003) Blood , vol.102 , Issue.3 , pp. 814-819
    • Giebel, S.1    Locatelli, F.2    Lamparelli, T.3
  • 111
    • 15244346488 scopus 로고    scopus 로고
    • Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-Term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
    • D. W. Beelen, H. D. Ottinger, S. Ferencik et al., "Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-Term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias, " Blood, vol. 105, no. 6, pp. 2594-2600, 2005.
    • (2005) Blood , vol.105 , Issue.6 , pp. 2594-2600
    • Beelen, D.W.1    Ottinger, H.D.2    Ferencik, S.3
  • 112
    • 34247581578 scopus 로고    scopus 로고
    • Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
    • J. S. Miller, S. Cooley, P. Parham et al., "Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT, " Blood, vol. 109, no. 11, pp. 5058-5061, 2007.
    • (2007) Blood , vol.109 , Issue.11 , pp. 5058-5061
    • Miller, J.S.1    Cooley, S.2    Parham, P.3
  • 113
    • 0042194439 scopus 로고    scopus 로고
    • Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
    • Y. K. Tam, J. A. Martinson, K. Doligosa, and H.-G. Klingemann, "Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy, " Cytotherapy, vol. 5, no. 3, pp. 259-272, 2003.
    • (2003) Cytotherapy , vol.5 , Issue.3 , pp. 259-272
    • Tam, Y.K.1    Martinson, J.A.2    Doligosa, K.3    Klingemann, H.-G.4
  • 114
    • 17444414991 scopus 로고    scopus 로고
    • Natural killer cell-based immunotherapeutic strategies
    • H.-G. Klingemann, "Natural killer cell-based immunotherapeutic strategies, " Cytotherapy, vol. 7, no. 1, pp. 16-22, 2005.
    • (2005) Cytotherapy , vol.7 , Issue.1 , pp. 16-22
    • Klingemann, H.-G.1
  • 115
    • 84894030202 scopus 로고    scopus 로고
    • Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
    • H. E. Kohrt, A. Thielens, A. Marabelle et al., "Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies, " Blood, vol. 123, no. 5, pp. 678-686, 2014.
    • (2014) Blood , vol.123 , Issue.5 , pp. 678-686
    • Kohrt, H.E.1    Thielens, A.2    Marabelle, A.3
  • 116
    • 69249108787 scopus 로고    scopus 로고
    • Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells
    • F. Romagn, P. Andr, P. Spee et al., "Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells, " Blood, vol. 114, no. 13, pp. 2667-2677, 2009.
    • (2009) Blood , vol.114 , Issue.13 , pp. 2667-2677
    • Romagn, F.1    Andr, P.2    Spee, P.3
  • 117
    • 0035874543 scopus 로고    scopus 로고
    • Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
    • C. Y. Koh, B. R. Blazar, T. George et al., "Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo, " Blood, vol. 97, no. 10, pp. 3132-3137, 2001.
    • (2001) Blood , vol.97 , Issue.10 , pp. 3132-3137
    • Koh, C.Y.1    Blazar, B.R.2    George, T.3
  • 118
    • 0027365746 scopus 로고
    • Molecular cloning of a ligand for the inducible T cell gene 4-1BB: Amember of an emerging family of cytokines with homology to tumor necrosis factor
    • R. G. Goodwin, W. S. Din, T. Davis-Smith et al., "Molecular cloning of a ligand for the inducible T cell gene 4-1BB: Amember of an emerging family of cytokines with homology to tumor necrosis factor, " European Journal of Immunology, vol. 23, no. 10, pp. 2631-2641, 1993.
    • (1993) European Journal of Immunology , vol.23 , Issue.10 , pp. 2631-2641
    • Goodwin, R.G.1    Din, W.S.2    Davis-Smith, T.3
  • 119
    • 0031007143 scopus 로고    scopus 로고
    • Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
    • I. Melero, W. W. Shuford, S. A. Newby et al., "Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors, " Nature Medicine, vol. 3, no. 6, pp. 682-685, 1997.
    • (1997) Nature Medicine , vol.3 , Issue.6 , pp. 682-685
    • Melero, I.1    Shuford, W.W.2    Newby, S.A.3
  • 120
    • 1442324410 scopus 로고    scopus 로고
    • Role of 4-1BB:4-1BB ligand in cancer immunotherapy
    • A. T. C. Cheuk, G. J. Mufti, and B.-A. Guinn, "Role of 4-1BB:4-1BB ligand in cancer immunotherapy, " Cancer Gene Therapy, vol. 11, no. 3, pp. 215-226, 2004.
    • (2004) Cancer Gene Therapy , vol.11 , Issue.3 , pp. 215-226
    • Cheuk, A.T.C.1    Mufti, G.J.2    Guinn, B.-A.3
  • 121
    • 17644389199 scopus 로고    scopus 로고
    • TNF/TNFR family members in costimulation of T cell responses
    • T.H. Watts, "TNF/TNFR family members in costimulation of T cell responses, " Annual Review of Immunology, vol. 23, pp. 23-68, 2005.
    • (2005) Annual Review of Immunology , vol.23 , pp. 23-68
    • Watts, T.H.1
  • 122
    • 33748286793 scopus 로고    scopus 로고
    • Dual immunoregulatory pathways of 4-1BB signaling
    • D. S. Vinay, K. Cha, and B. S. Kwon, "Dual immunoregulatory pathways of 4-1BB signaling, " Journal of Molecular Medicine, vol. 84, no. 9, pp. 726-736, 2006.
    • (2006) Journal of Molecular Medicine , vol.84 , Issue.9 , pp. 726-736
    • Vinay, D.S.1    Cha, K.2    Kwon, B.S.3
  • 123
    • 0034541168 scopus 로고    scopus 로고
    • Role of TNF receptorassociated factor 2 and p38 mitogen-Activated protein kinase activation during 4-1BB-dependent immune response
    • J. L. Cannons, Y. Choi, and T. H. Watts, "Role of TNF receptorassociated factor 2 and p38 mitogen-Activated protein kinase activation during 4-1BB-dependent immune response, " Journal of Immunology, vol. 165, no. 11, pp. 6193-6204, 2000.
    • (2000) Journal of Immunology , vol.165 , Issue.11 , pp. 6193-6204
    • Cannons, J.L.1    Choi, Y.2    Watts, T.H.3
  • 124
    • 0036838689 scopus 로고    scopus 로고
    • 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-L and Bfl-1
    • H.-W. Lee, S.-J. Park, B. K. Choi, H.H. Kim, K.-O. Nam, and B. S. Kwon, "4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-L and Bfl-1, " The Journal of Immunology, vol. 169, no. 9, pp. 4882-4888, 2002.
    • (2002) The Journal of Immunology , vol.169 , Issue.9 , pp. 4882-4888
    • Lee, H.-W.1    Park, S.-J.2    Choi, B.K.3    Kim, H.H.4    Nam, K.-O.5    Kwon, B.S.6
  • 126
    • 0036083989 scopus 로고    scopus 로고
    • T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer
    • O. Martinet, C. M. Divino, Y. Zang et al., "T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancer, " Gene Therapy, vol. 9, no. 12, pp. 786-792, 2002.
    • (2002) Gene Therapy , vol.9 , Issue.12 , pp. 786-792
    • Martinet, O.1    Divino, C.M.2    Zang, Y.3
  • 127
    • 0034218442 scopus 로고    scopus 로고
    • Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation
    • S.-H. Chen, K. B. Pham-Nguyen, O. Martinet et al., "Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation, " Molecular Therapy, vol. 2, no. 1, pp. 39-46, 2000.
    • (2000) Molecular Therapy , vol.2 , Issue.1 , pp. 39-46
    • Chen, S.-H.1    Pham-Nguyen, K.B.2    Martinet, O.3
  • 128
    • 0035266427 scopus 로고    scopus 로고
    • Divergent effects of 4-1BB antibodies on antitumor immunity and on tumorreactive T-cell generation
    • J. A. Kim, B. J. Averbook, K. Chambers et al., "Divergent effects of 4-1BB antibodies on antitumor immunity and on tumorreactive T-cell generation, " Cancer Research, vol. 61, no. 5, pp. 2031-2037, 2001.
    • (2001) Cancer Research , vol.61 , Issue.5 , pp. 2031-2037
    • Kim, J.A.1    Averbook, B.J.2    Chambers, K.3
  • 129
    • 0033938756 scopus 로고    scopus 로고
    • Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma
    • S. E. Strome, B. Martin, D. Flies et al., "Enhanced therapeutic potential of adoptive immunotherapy by in vitro CD28/4-1BB costimulation of tumor-reactive T cells against a poorly immunogenic, major histocompatibility complex class I-negative A9P melanoma, " Journal of Immunotherapy, vol. 23, no. 4, pp. 430-437, 2000.
    • (2000) Journal of Immunotherapy , vol.23 , Issue.4 , pp. 430-437
    • Strome, S.E.1    Martin, B.2    Flies, D.3
  • 130
    • 0038181099 scopus 로고    scopus 로고
    • Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy
    • Q. Li, A. Carr, F. Ito, S. Teitz-Tennenbaum, and A. E. Chang, "Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy, " Cancer Research, vol. 63, no. 10, pp. 2546-2552, 2003.
    • (2003) Cancer Research , vol.63 , Issue.10 , pp. 2546-2552
    • Li, Q.1    Carr, A.2    Ito, F.3    Teitz-Tennenbaum, S.4    Chang, A.E.5
  • 131
    • 0031906785 scopus 로고    scopus 로고
    • Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 costimulatory pathway
    • I. Melero, N. Bach, K. E. Hellstrm, A. Aruffo, R. S. Mittler, and L. Chen, "Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 costimulatory pathway, " European Journal of Immunology, vol. 28, no. 3, pp. 1116-1121, 1998.
    • (1998) European Journal of Immunology , vol.28 , Issue.3 , pp. 1116-1121
    • Melero, I.1    Bach, N.2    Hellstrm, K.E.3    Aruffo, A.4    Mittler, R.S.5    Chen, L.6
  • 132
    • 0033560179 scopus 로고    scopus 로고
    • 4-IBBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine
    • B.-A. Guinn, M. A. DeBenedette, T. H. Watts, and N. L. Berinstein, "4-IBBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine, " The Journal of Immunology, vol. 162, no. 8, pp. 5003-5010, 1999.
    • (1999) The Journal of Immunology , vol.162 , Issue.8 , pp. 5003-5010
    • Guinn, B.-A.1    DeBenedette, M.A.2    Watts, T.H.3    Berinstein, N.L.4
  • 133
    • 0034536944 scopus 로고    scopus 로고
    • Tumour rejection by gene transfer of 4-1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells
    • S. Mogi, J. Sakurai, T. Kohsaka et al., "Tumour rejection by gene transfer of 4-1BB ligand into a CD80+ murine squamous cell carcinoma and the requirements of co-stimulatory molecules on tumour and host cells, " Immunology, vol. 101, no. 4, pp. 541-547, 2000.
    • (2000) Immunology , vol.101 , Issue.4 , pp. 541-547
    • Mogi, S.1    Sakurai, J.2    Kohsaka, T.3
  • 134
    • 0032823594 scopus 로고    scopus 로고
    • Expression of Co-stimulatory 4-1BB ligand induces significant tumor regression and protective immunity
    • J. Xiang, "Expression of Co-stimulatory 4-1BB ligand induces significant tumor regression and protective immunity, " Cancer Biotherapy and Radiopharmaceuticals, vol. 14, no. 5, pp. 353-361, 1999.
    • (1999) Cancer Biotherapy and Radiopharmaceuticals , vol.14 , Issue.5 , pp. 353-361
    • Xiang, J.1
  • 135
    • 0033602151 scopus 로고    scopus 로고
    • Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR
    • A. L. Gurney, S. A. Marsters, A. Huang et al., "Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR, " Current Biology, vol. 9, no. 4, pp. 215-218, 1999.
    • (1999) Current Biology , vol.9 , Issue.4 , pp. 215-218
    • Gurney, A.L.1    Marsters, S.A.2    Huang, A.3
  • 136
    • 0033525904 scopus 로고    scopus 로고
    • Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand
    • B. Kwon, K.-Y. Yu, J. Ni et al., "Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand, " The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6056-6061, 1999.
    • (1999) The Journal of Biological Chemistry , vol.274 , Issue.10 , pp. 6056-6061
    • Kwon, B.1    Yu, K.-Y.2    Ni, J.3
  • 137
    • 0036195161 scopus 로고    scopus 로고
    • CD4+CD25+ immunoregulatory T cells: Gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor
    • R. S. McHugh, M. J. Whitters, C. A. Piccirillo et al., "CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor, " Immunity, vol. 16, no. 2, pp. 311-323, 2002.
    • (2002) Immunity , vol.16 , Issue.2 , pp. 311-323
    • McHugh, R.S.1    Whitters, M.J.2    Piccirillo, C.A.3
  • 138
    • 0036170938 scopus 로고    scopus 로고
    • Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-Tolerance
    • J. Shimizu, S. Yamazaki, T. Takahashi, Y. Ishida, and S. Sakaguchi, "Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-Tolerance, " Nature Immunology, vol. 3, no. 2, pp. 135-142, 2002.
    • (2002) Nature Immunology , vol.3 , Issue.2 , pp. 135-142
    • Shimizu, J.1    Yamazaki, S.2    Takahashi, T.3    Ishida, Y.4    Sakaguchi, S.5
  • 139
    • 1642379813 scopus 로고    scopus 로고
    • Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations
    • S. Ronchetti, O. Zollo, S. Bruscoli et al., "Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations, " European Journal of Immunology, vol. 34, no. 3, pp. 613-622, 2004.
    • (2004) European Journal of Immunology , vol.34 , Issue.3 , pp. 613-622
    • Ronchetti, S.1    Zollo, O.2    Bruscoli, S.3
  • 140
    • 1842424807 scopus 로고    scopus 로고
    • Ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis
    • A. P. Kohm, J. S. Williams, and S. D. Miller, "Ligation of the glucocorticoid-induced TNF receptor enhances autoreactive CD4+ T cell activation and experimental autoimmune encephalomyelitis, " The Journal of Immunology, vol. 172, no. 8, pp. 4686-4690, 2004.
    • (2004) The Journal of Immunology , vol.172 , Issue.8 , pp. 4686-4690
    • Kohm, A.P.1    Williams, J.S.2    Miller, S.D.3
  • 141
    • 2942532501 scopus 로고    scopus 로고
    • Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells
    • F. Kanamaru, P. Youngnak, M. Hashiguchi et al., "Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells, " Journal of Immunology, vol. 172, no. 12, pp. 7306-7314, 2004.
    • (2004) Journal of Immunology , vol.172 , Issue.12 , pp. 7306-7314
    • Kanamaru, F.1    Youngnak, P.2    Hashiguchi, M.3
  • 142
    • 17444414236 scopus 로고    scopus 로고
    • GITR: A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily
    • G. Nocentini and C. Riccardi, "GITR: A multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily, " European Journal of Immunology, vol. 35, no. 4, pp. 1016-1022, 2005.
    • (2005) European Journal of Immunology , vol.35 , Issue.4 , pp. 1016-1022
    • Nocentini, G.1    Riccardi, C.2
  • 143
    • 4344608128 scopus 로고    scopus 로고
    • Constitutive and cytokineinduced GITR ligand expression on human retinal pigment epithelium and photoreceptors
    • B. J. Kim, Z. Li, R. N. Fariss et al., "Constitutive and cytokineinduced GITR ligand expression on human retinal pigment epithelium and photoreceptors, " Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3170-3176, 2004.
    • (2004) Investigative Ophthalmology and Visual Science , vol.45 , Issue.9 , pp. 3170-3176
    • Kim, B.J.1    Li, Z.2    Fariss, R.N.3
  • 144
    • 33746575650 scopus 로고    scopus 로고
    • The GITR-GITRL interaction: Co-stimulation or contrasuppression of regulatory activity?
    • E. M. Shevach and G. L. Stephens, "The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?" Nature Reviews Immunology, vol. 6, no. 8, pp. 613-618, 2006.
    • (2006) Nature Reviews Immunology , vol.6 , Issue.8 , pp. 613-618
    • Shevach, E.M.1    Stephens, G.L.2
  • 145
    • 84897933432 scopus 로고    scopus 로고
    • GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability
    • D. A. Schaer, "GITR pathway activation abrogates tumor immune suppression through loss of regulatory T cell lineage stability, " Cancer Immunology Research, vol. 1, no. 5, pp. 320-331, 2013.
    • (2013) Cancer Immunology Research , vol.1 , Issue.5 , pp. 320-331
    • Schaer, D.A.1
  • 146
    • 84862769116 scopus 로고    scopus 로고
    • An immune-Active tumor microenvironment favors clinical response to ipilimumab
    • R.-R. Ji, S. D. Chasalow, L. Wang et al., "An immune-Active tumor microenvironment favors clinical response to ipilimumab, " Cancer Immunology, Immunotherapy, vol. 61, no. 7, pp. 1019-1031, 2012.
    • (2012) Cancer Immunology, Immunotherapy , vol.61 , Issue.7 , pp. 1019-1031
    • Ji, R.-R.1    Chasalow, S.D.2    Wang, L.3
  • 147
    • 23444462753 scopus 로고    scopus 로고
    • Role of glucocorticoid-induced TNF receptor family gene (GITR) in collageninduced arthritis
    • S. Cuzzocrea, E. Ayroldi, R. Di Paola et al., "Role of glucocorticoid-induced TNF receptor family gene (GITR) in collageninduced arthritis, " The FASEB Journal, vol. 19, no. 10, pp. 1253-1265, 2005.
    • (2005) The FASEB Journal , vol.19 , Issue.10 , pp. 1253-1265
    • Cuzzocrea, S.1    Ayroldi, E.2    Di Paola, R.3
  • 148
    • 29744441207 scopus 로고    scopus 로고
    • Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis
    • M. Patel, D. Xu, P. Kewin et al., "Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis, " European Journal of Immunology, vol. 35, no. 12, pp. 3581-3590, 2005.
    • (2005) European Journal of Immunology , vol.35 , Issue.12 , pp. 3581-3590
    • Patel, M.1    Xu, D.2    Kewin, P.3
  • 149
    • 84859567294 scopus 로고    scopus 로고
    • Glucocorticoid-induced TNF receptor-Triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke
    • M. Takata, T. Nakagomi, S. Kashiwamura et al., "Glucocorticoid-induced TNF receptor-Triggered T cells are key modulators for survival/death of neural stem/progenitor cells induced by ischemic stroke, " Cell Death and Differentiation, vol. 19, no. 5, pp. 756-767, 2012.
    • (2012) Cell Death and Differentiation , vol.19 , Issue.5 , pp. 756-767
    • Takata, M.1    Nakagomi, T.2    Kashiwamura, S.3
  • 150
    • 77955279163 scopus 로고    scopus 로고
    • Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-Tumor accumulation
    • Article ID e10436
    • A. D. Cohen, D. A. Schaer, C. Liu et al., "Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-Tumor accumulation, " PLoS ONE, vol. 5, no. 5, Article ID e10436, 2010.
    • (2011) PLoS ONE , vol.5 , Issue.5
    • Cohen, A.D.1    Schaer, D.A.2    Liu, C.3
  • 151
    • 6344279933 scopus 로고    scopus 로고
    • Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ Tcells
    • G. L. Stephens, R. S. McHugh, M. J. Whitters et al., "Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ Tcells, "The Journal of Immunology, vol. 173, no. 8, pp. 5008-5020, 2004.
    • (2004) The Journal of Immunology , vol.173 , Issue.8 , pp. 5008-5020
    • Stephens, G.L.1    McHugh, R.S.2    Whitters, M.J.3
  • 154
    • 67449110979 scopus 로고    scopus 로고
    • Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
    • D.-M. Kuang, Q. Zhao, C. Peng et al., "Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1, " The Journal of Experimental Medicine, vol. 206, no. 6, pp. 1327-1337, 2009.
    • (2009) The Journal of Experimental Medicine , vol.206 , Issue.6 , pp. 1327-1337
    • Kuang, D.-M.1    Zhao, Q.2    Peng, C.3
  • 155
    • 79959549102 scopus 로고    scopus 로고
    • Tumorinfiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer
    • J. Krempski, L. Karyampudi, M. D. Behrens et al., "Tumorinfiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer, " The Journal of Immunology, vol. 186, no. 12, pp. 6905-6913, 2011.
    • (2011) The Journal of Immunology , vol.186 , Issue.12 , pp. 6905-6913
    • Krempski, J.1    Karyampudi, L.2    Behrens, M.D.3
  • 156
    • 77953422225 scopus 로고    scopus 로고
    • Combination approaches to immunotherapy: The radiotherapy example
    • M. J. Gough and M. R. Crittenden, "Combination approaches to immunotherapy: The radiotherapy example, " Immunotherapy, vol. 1, no. 6, pp. 1025-1037, 2009.
    • (2009) Immunotherapy , vol.1 , Issue.6 , pp. 1025-1037
    • Gough, M.J.1    Crittenden, M.R.2
  • 157
    • 0032966188 scopus 로고    scopus 로고
    • The molecular and cellular basis of radiosensitivity: Implications for understanding how normal tissues and tumors respond to therapeutic radiation
    • E. M. Rosen, S. Fan, S. Rockwell, and I. D. Goldberg, "The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation, " Cancer Investigation, vol. 17, no. 1, pp. 56-72, 1999.
    • (1999) Cancer Investigation , vol.17 , Issue.1 , pp. 56-72
    • Rosen, E.M.1    Fan, S.2    Rockwell, S.3    Goldberg, I.D.4
  • 158
    • 80051693219 scopus 로고    scopus 로고
    • Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide
    • S. A. Grossman, X. Ye, G. Lesser et al., "Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide, " Clinical Cancer Research, vol. 17, no. 16, pp. 5473-5480, 2011.
    • (2011) Clinical Cancer Research , vol.17 , Issue.16 , pp. 5473-5480
    • Grossman, S.A.1    Ye, X.2    Lesser, G.3
  • 159
    • 3843124144 scopus 로고    scopus 로고
    • A sense of danger from radiation
    • W. H. McBride, C.-S. Chiang, J. L. Olson et al., "A sense of danger from radiation, " Radiation Research, vol. 162, no. 1, pp. 1-19, 2004.
    • (2004) Radiation Research , vol.162 , Issue.1 , pp. 1-19
    • McBride, W.H.1    Chiang, C.-S.2    Olson, J.L.3
  • 160
    • 36849031260 scopus 로고    scopus 로고
    • Sensors of ionizing radiation effects on the immunological microenvironment of cancer
    • S. Demaria and S. C. Formenti, "Sensors of ionizing radiation effects on the immunological microenvironment of cancer, " International Journal of Radiation Biology, vol. 83, no. 11-12, pp. 819-825, 2007.
    • (2007) International Journal of Radiation Biology , vol.83 , Issue.11-12 , pp. 819-825
    • Demaria, S.1    Formenti, S.C.2
  • 161
    • 0032485487 scopus 로고    scopus 로고
    • Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLS
    • M. L. Albert, B. Sauter, and N. Bhardwaj, "Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLS, " Nature, vol. 392, no. 6671, pp. 86-89, 1998.
    • (1998) Nature , vol.392 , Issue.6671 , pp. 86-89
    • Albert, M.L.1    Sauter, B.2    Bhardwaj, N.3
  • 162
    • 0035988623 scopus 로고    scopus 로고
    • Immune modulation by ionizing radiation and its implications for cancer immunotherapy
    • E. J. Friedman, "Immune modulation by ionizing radiation and its implications for cancer immunotherapy, " Current Pharmaceutical Design, vol. 8, no. 19, pp. 1765-1780, 2002.
    • (2002) Current Pharmaceutical Design , vol.8 , Issue.19 , pp. 1765-1780
    • Friedman, E.J.1
  • 163
    • 0034614897 scopus 로고    scopus 로고
    • Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
    • B. Sauter, M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj, "Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells, " Journal of ExperimentalMedicine, vol. 191, no. 3, pp. 423-433, 2000.
    • (2000) Journal of ExperimentalMedicine , vol.191 , Issue.3 , pp. 423-433
    • Sauter, B.1    Albert, M.L.2    Francisco, L.3    Larsson, M.4    Somersan, S.5    Bhardwaj, N.6
  • 164
    • 14744292280 scopus 로고    scopus 로고
    • Downregulation of major histocompatibility complex antigens in invading glioma cells: Stealth invasion of the brain
    • D. Zagzag, K. Salnikow, L. Chiriboga et al., "Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain, " Laboratory Investigation, vol. 85, no. 3, pp. 328-341, 2005.
    • (2005) Laboratory Investigation , vol.85 , Issue.3 , pp. 328-341
    • Zagzag, D.1    Salnikow, K.2    Chiriboga, L.3
  • 165
    • 0036569659 scopus 로고    scopus 로고
    • A functional role of HLA-G expression in human gliomas: An alternative strategy ofimmune escape
    • H. Wiendl, M. Mitsdoerffer, V. Hofmeister et al., "A functional role of HLA-G expression in human gliomas: An alternative strategy ofimmune escape, "TheJournal of Immunology, vol. 168, no. 9, pp. 4772-4780, 2002.
    • (2002) TheJournal of Immunology , vol.168 , Issue.9 , pp. 4772-4780
    • Wiendl, H.1    Mitsdoerffer, M.2    Hofmeister, V.3
  • 166
    • 33748085015 scopus 로고    scopus 로고
    • The combination of ionizing radiation and peripheral vaccination produces long-Term survival of mice bearing established invasive GL261 gliomas
    • E.W. Newcomb, S. Demaria, Y. Lukyanov et al., "The combination of ionizing radiation and peripheral vaccination produces long-Term survival of mice bearing established invasive GL261 gliomas, " Clinical Cancer Research, vol. 12, no. 15, pp. 4730-4737, 2006.
    • (2006) Clinical Cancer Research , vol.12 , Issue.15 , pp. 4730-4737
    • Newcomb, E.W.1    Demaria, S.2    Lukyanov, Y.3
  • 167
    • 12244252335 scopus 로고    scopus 로고
    • Immunemediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer
    • S. Demaria, N. Kawashima, A. M. Yang et al., "Immunemediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer, " Clinical Cancer Research, vol. 11, no. 2, part 1, pp. 728-734, 2005.
    • (2005) Clinical Cancer Research , vol.11 , Issue.2 , pp. 728-734
    • Demaria, S.1    Kawashima, N.2    Yang, A.M.3
  • 168
    • 69949085196 scopus 로고    scopus 로고
    • Fractionated but not single-dose radiotherapy induces an immunemediated abscopal effect when combined with anti-CTLA-4 antibody
    • M. Z. Dewan, A. E. Galloway, N. Kawashima et al., "Fractionated but not single-dose radiotherapy induces an immunemediated abscopal effect when combined with anti-CTLA-4 antibody, " Clinical Cancer Research, vol. 15, no. 17, pp. 5379-5388, 2009.
    • (2009) Clinical Cancer Research , vol.15 , Issue.17 , pp. 5379-5388
    • Dewan, M.Z.1    Galloway, A.E.2    Kawashima, N.3
  • 169
    • 84904216679 scopus 로고    scopus 로고
    • Ipilimumab and radiation therapy for melanoma brain metastases
    • A. W. Silk, M. F. Bassetti, B. T. West, C. I. Tsien, and C. D. Lao, "Ipilimumab and radiation therapy for melanoma brain metastases, " Cancer Medicine, vol. 2, no. 6, pp. 899-906, 2013.
    • (2013) Cancer Medicine , vol.2 , Issue.6 , pp. 899-906
    • Silk, A.W.1    Bassetti, M.F.2    West, B.T.3    Tsien, C.I.4    Lao, C.D.5
  • 170
    • 84859629008 scopus 로고    scopus 로고
    • Adult glioblastoma multiforme survival in the temozolomide era: A populationbased analysis of surveillance, epidemiology, and end results registries
    • A. S. Darefsky, J. T. King Jr., and R. Dubrow, "Adult glioblastoma multiforme survival in the temozolomide era: A populationbased analysis of surveillance, epidemiology, and end results registries, " Cancer, vol. 118, no. 8, pp. 2163-2172, 2012.
    • (2012) Cancer , vol.118 , Issue.8 , pp. 2163-2172
    • Darefsky, A.S.1    King, J.T.2    Dubrow, R.3
  • 171
    • 84908563697 scopus 로고    scopus 로고
    • Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): A multicentre, randomised, openlabel, phase 3 trial
    • R. Stupp, M. E. Hegi, T. Gorlia et al., "Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): A multicentre, randomised, openlabel, phase 3 trial, "TheLancetOncology, vol. 15, no. 10, pp. 1100-1108, 2014.
    • (2014) TheLancetOncology , vol.15 , Issue.10 , pp. 1100-1108
    • Stupp, R.1    Hegi, M.E.2    Gorlia, T.3
  • 172
    • 0028074499 scopus 로고
    • Lymphocyte depletion during treatment with intensive chemotherapy for cancer
    • C. L. Mackall, T. A. Fleisher, M. R. Brown et al., "Lymphocyte depletion during treatment with intensive chemotherapy for cancer, " Blood, vol. 84, no. 7, pp. 2221-2228, 1994.
    • (1994) Blood , vol.84 , Issue.7 , pp. 2221-2228
    • Mackall, C.L.1    Fleisher, T.A.2    Brown, M.R.3
  • 173
    • 1442283179 scopus 로고    scopus 로고
    • Selective CD4+ lymphopenia inmelanoma patients treated with temozolomide: A toxicity with therapeutic implications
    • Y. B. Su, S. Sohn, S. E. Krown et al., "Selective CD4+ lymphopenia inmelanoma patients treated with temozolomide: A toxicity with therapeutic implications, " Journal of Clinical Oncology, vol. 22, no. 4, pp. 610-616, 2004.
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.4 , pp. 610-616
    • Su, Y.B.1    Sohn, S.2    Krown, S.E.3
  • 174
    • 70450185084 scopus 로고    scopus 로고
    • Immunotherapy combined with chemotherapy in the treatment of tumors
    • J. L. Frazier, J. E. Han, M. Lim, and A. Olivi, "Immunotherapy combined with chemotherapy in the treatment of tumors, " Neurosurgery Clinics ofNorth America, vol. 21, no. 1, pp. 187-194, 2010.
    • (2011) Neurosurgery Clinics OfNorth America , vol.21 , Issue.1 , pp. 187-194
    • Frazier, J.L.1    Han, J.E.2    Lim, M.3    Olivi, A.4
  • 175
    • 34547838615 scopus 로고    scopus 로고
    • Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model
    • S. Brem, B. Tyler, K. Li et al., "Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model, " Cancer Chemotherapy and Pharmacology, vol. 60, no. 5, pp. 643-650, 2007.
    • (2007) Cancer Chemotherapy and Pharmacology , vol.60 , Issue.5 , pp. 643-650
    • Brem, S.1    Tyler, B.2    Li, K.3
  • 176
    • 84883445769 scopus 로고    scopus 로고
    • Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion
    • S. Fritzell, E. Sandn, S. Eberstal, E. Visse, A. Darabi, and P. Siesj, "Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion, " Cancer Immunology, Immunotherapy, vol. 62, no. 9, pp. 1463-1474, 2013.
    • (2013) Cancer Immunology, Immunotherapy , vol.62 , Issue.9 , pp. 1463-1474
    • Fritzell, S.1    Sandn, E.2    Eberstal, S.3    Visse, E.4    Darabi, A.5    Siesj, P.6
  • 177
    • 68549112974 scopus 로고    scopus 로고
    • Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
    • C. Banissi, F. Ghiringhelli, L. Chen, and A. F. Carpentier, "Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model, " Cancer Immunology, Immunotherapy, vol. 58, no. 10, pp. 1627-1634, 2009.
    • (2009) Cancer Immunology, Immunotherapy , vol.58 , Issue.10 , pp. 1627-1634
    • Banissi, C.1    Ghiringhelli, F.2    Chen, L.3    Carpentier, A.F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.